Global melanoma leadership

Institutional leadership

Mapping the roles, mandates, and academic journey that anchor credibility.

Current leadership map

Chairman of the Ella Lemelbaum Immuno-Oncology and Melanoma Institute, and senior advisor to leading private hospitals delivering dual public-private influence.

Academic foundation

From Hebrew University medical training through NIH/NCI fellowship and Sackler professorship, every stage reinforced translational immunology.

1969-1976

Hebrew University Hadassah Medical School (MD).

1982-1986

Oncology residency at Beilinson (Rabin) Medical Center.

1986

NIH/NCI fellowship during the formative era of adoptive immunotherapy.

2010

Professor of Oncology at the Tel Aviv University School of Medicine.

Career highlights

2004 — Launches Ella Lemelbaum Institute as a bench-to-bedside ecosystem with in-house GMP labs.
2006 — National Cancer Association prize for bringing TIL therapy to Israel.
Chair of Israel’s oncology curriculum committee, shaping how future clinicians are trained.

Therapeutic philosophy

Customized care that trusts the immune system’s potential, balancing evidence, compassion, and rapid adoption of validated innovations.

Ella Institute operates as a "Center of Excellence" that unites inpatient care, research labs, and GMP manufacturing under one strategy.